| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000236859.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045762687 |
Resistant |
| ENSG00000236859.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.015815756 |
Sensitive |
| ENSG00000236859.2 |
Cytarabine |
Sarcoma |
0.021335156 |
Sensitive |
